Lake Erie Medical DBA Quality Care Products LLC Products: Prescription Medications Section

Page 1 of 73 1 2 3 4 5 … 10 15 20 25 30 … » Last Page »

Abilify (Aripiprazole)

1 INDICATIONS AND USAGE 1.1 Schizophrenia ABILIFY is indicated for the treatment of schizophrenia. The efficacy of ABILIFY was established in four 4-6 week trials in adults and one 6-week trial in adolescents (13 to 17 years). Maintenance efficacy…

Lake Erie Medical DBA Quality Care Products LLC3 June 2010

ACETAMINOPHEN AND CODEINE PHOSPHATE

Acetaminophen and codeine phosphate tablets are indicated for the relief of mild to moderately severe pain. CONTRAINDICATIONS: Codeine-containing products are contraindicated for…

Lake Erie Medical DBA Quality Care Products LLC13 November 2019

Acetic Acid

For the treatment of superficial infections of the external auditory canal caused by organisms susceptible to the action of the antimicrobial. CONTRAINDICATIONS: Hypersensitivity to…

Lake Erie Medical DBA Quality Care Products LLC19 May 2020

Acyclovir

Herpes Zoster Infections: Acyclovir tablets are indicated for the acute treatment of herpes zoster (shingles). Genital Herpes: Acyclovir tablets are indicated for the treatment of initial…

Lake Erie Medical DBA Quality Care Products LLC15 January 2020

Albuterol Sulfate

Albuterol Sulfate Syrup is indicated for the relief of bronchospasm in adults and children 2 years of age and older with reversible obstructive airway disease. CONTRAINDICATIONS: Albuterol Sulfate Syrup is contraindicated in patients with a history…

Lake Erie Medical DBA Quality Care Products LLC4 February 2011

Page 1 of 73 1 2 3 4 5 … 10 15 20 25 30 … » Last Page »

FDA Medwatch

Acella Pharmaceuticals, LLC Issues Voluntary Nationwide Recall of Certain Lots of NP Thyroid® (Thyroid Tablets, USP) Due to Super Potency
Thu, 21 May 2020. Acella Pharmaceuticals, LLC is voluntarily recalling a total of 13 lots of 30-mg, 60-mg and 90-mg NP Thyroid® (thyroid tablets, USP) to the consumer level. The products are being recalled because our testing has found these lots to be superpotent…
Biota Biosciences Issues Voluntary Nationwide Recall of Cannabidiol (CBD) Complex, Curcumin Complex, and Cannabidiol + Curcumin Injectables Because They Were Marketed Without FDA Approval
Tue, 19 May 2020. Biota Biosciences is voluntarily recalling the following lots in the table below of Cannabidiol (CBD) Complex, Curcumin Complex, and Cannabidiol + Curcumin Injectables to the customer level.

MedLibrary.org

Medication Sections

RSS Feeds

About

This site is provided for educational and informational purposes only, in accordance with our Terms of Use, and is not intended as a substitute for the advice of a medical doctor, nurse, nurse practitioner or other qualified health professional.